<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02890186</url>
  </required_header>
  <id_info>
    <org_study_id>double closed-loop</org_study_id>
    <nct_id>NCT02890186</nct_id>
  </id_info>
  <brief_title>Dual-loop Target Controlled Infusion for Coadministration of Propofol and Remifentanil Guided by Narcotrend Index</brief_title>
  <official_title>Dual-loop Target Controlled Infusion for Coadministration of Propofol and Remifentanil Guided by Narcotrend Index in Anterior Cervical Decompression and Fusion With Internal Fixation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou General Hospital of Guangzhou Military Command</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou General Hospital of Guangzhou Military Command</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the application of closed target-controlled infusion(TCI) of propofol and
      remifentanil guided by Narcotrend index in the anterior cervical decompression and fusion
      with internal fixation surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sixty patients scheduled for anterior cervical decompression and fusion with internal
      fixation surgery under general anesthesia were randomly divided into two groups:closed-loop
      (group A,n=30) and open-loop group(group B,n=30).The procedure during induction of anesthesia
      was same in two groups.In group A,if Narcotrend index(NI) fall down to 46 and keep more than
      30 seconds,propofol and remifentanil were intravenously infused as feedback automatically to
      achieve the target NI of 26-46.However,the NI in group B was controlled manually.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the total dose of propofol and remifentanil</measure>
    <time_frame>within three hours from the beginning to the end of the propofol and remifentanil</time_frame>
    <description>record the total dose of propofol and remifentanil from the beginning to the end of anesthesia</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Dual-Loop TCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the investigator modified the effect-site target concentrations by NI.If NI fall down to 46 and keep 46 more than 30 seconds,propofol and remifentanil were infused as feedback automatically to achieve the target NI of 26-46.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>manual</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>the investigator modified the effect-site target concentrations of both drugs without minimum or maximum concentration limits without using the Narcotrend monitor only depend on the experience of anesthesiologist.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Narcotrend</intervention_name>
    <description>the investigator modified the effect-site target concentrations by NI.If NI fall down to 46 and keep 46 more than 30 seconds,propofol and remifentanil were infused as feedback automatically to achieve the target NI of 26-46.</description>
    <arm_group_label>Dual-Loop TCI</arm_group_label>
    <other_name>Dual-Loop Target Controlled Infusion of Propofol and Remifentanil Guided by Narcotrend Index</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>experience</intervention_name>
    <description>the investigator modified the effect-site target concentrations of both drugs without minimum or maximum concentration limits without using the Narcotrend monitor only depend on the experience of anesthesiologist.</description>
    <arm_group_label>manual</arm_group_label>
    <other_name>Control infusion of propofol and remifentanil guided by experience</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. ASA Ⅰ ~ Ⅱ women undergoing Laparoscopic surgery.

          2. Written informed consent from the patient or the relatives of the participating
             patient.

          3. BMI:18.0～25 kg/m2

        Exclusion Criteria:

          1. Mental illness can not match

          2. epidural anesthesia contraindicated

          3. People who have Slow-type arrhythmias

          4. Chronic renal failure

          5. Alcohol or drug abuse

          6. Already taking gabapentin, pregabalin, benzodiazepin or antidepression drug
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>23 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>bo Xu</last_name>
    <phone>88653387</phone>
    <phone_ext>020</phone_ext>
    <email>xubo333@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guangzhou Military Region General Hospital, Department of Anesthesiology</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ying Liu</last_name>
      <phone>13925189326</phone>
      <phone_ext>86</phone_ext>
      <email>354109813@qq.com</email>
    </contact>
    <investigator>
      <last_name>Ying Liu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2016</study_first_submitted>
  <study_first_submitted_qc>August 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2016</study_first_posted>
  <last_update_submitted>August 31, 2016</last_update_submitted>
  <last_update_submitted_qc>August 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangzhou General Hospital of Guangzhou Military Command</investigator_affiliation>
    <investigator_full_name>bo xu</investigator_full_name>
    <investigator_title>associate chief physician</investigator_title>
  </responsible_party>
  <keyword>narcotrend</keyword>
  <keyword>propofol</keyword>
  <keyword>remifentanil</keyword>
  <keyword>closed-loop of target controlled infusion</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

